Mig Dla Dzieci (Ibuprofen)

Ibuprofen works by blocking the cyclooxygenase enzymes COX‑1 and COX‑2, which are needed to produce prostaglandins. By lowering prostaglandin levels, it diminishes the signals that cause pain, fever, and swelling.

The appropriate dose of Mig Dla Dzieci is determined by a qualified prescriber based on the child’s age, weight, and clinical condition. Caregivers should follow the healthcare professional’s instructions and the product label precisely.

Ibuprofen is generally not recommended during the third trimester of pregnancy and should be used only if clearly needed under medical advice. While short‑term use during breastfeeding is considered compatible by many guidelines, a healthcare provider should evaluate the risk‑benefit balance for each individual case.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

The main alternative class is acetaminophen (paracetamol). Ibuprofen, the active ingredient in Mig Dla Dzieci, has anti‑inflammatory properties in addition to analgesic and antipyretic effects, whereas acetaminophen lacks significant anti‑inflammatory activity. Choice between them depends on the clinical scenario, safety profile, and physician preference.

Mig Dla Dzieci should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Mig Dla Dzieci is taken orally. The exact form (e.g., liquid suspension or chewable tablet) is specified on the label, and the dose should be measured with the device provided or as directed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, and kidney injury, especially when used at high doses or in children with pre‑existing renal problems. Prompt medical attention is required if any of these symptoms occur.

Mig Dla Dzieci should be avoided in children with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcer disease, severe renal or hepatic impairment, and in the third trimester of pregnancy. Consultation with a healthcare provider is essential before use in any of these situations.